# OnCo record pheast-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pheast-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pheast-therapeutics" ;
  schema:name "Pheast Therapeutics"@en ;
  schema:description "Pheast Therapeutics makes an antibody that removes a 'don't eat me' signal, CD24, that cancer cells use to hide from macrophages, immune cells that swallow and destroy them. It is in a first trial in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/pheast-therapeutics/>, <https://www.pheast.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.pheast.com/>, <https://www.pheast.com/news/pheast-therapeutics-announces-first-patient-treated-in-phase-1-clinical-trial-of-phst001-for-patients-with-advanced-solid-tumors>, <https://www.pheast.com/news/pheast-therapeutics-reports-initial-phase-1a-data-showing-early-clinical-activity-and-target-engagement-for-phst001-at-aacr-2026>, <https://clinicaltrials.gov/study/NCT06840886> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/cd24/> .